2018 QCDR and Qualified Registry Quality Payment Program Self-Nomination Process for Vendors

Articles


Hello, and thank you for joining today’s 2018
QCDR and Qualified Registry QPP Self-Nomination Process for Vendors. Today, representatives from the Centers for
Medicare & Medicaid Services will provide an overview on the Qualified Clinical Data
Registry and the self-nomination process for vendors. During the webinar, there will be a demonstration
on how to complete the 2018 JIRA self-nomination forms, as well as resources and where to find
additional assistance. You can listen to the presentation through
your computer speakers. If you cannot hear audio through your computer
speakers, please contact [email protected] Questions will be taken via the question box
only. Subject-matter experts will address any questions
as time permits. Any questions not answered on the phone will
be directed to [email protected] I would now like to introduce Dr. Daniel Green,
Medical Officer at CMS and the Quality Measurement and Health Assessment Group working at PQRS. Dr. Green, you may now begin. Hi, everybody. Thank you. Hi, everybody. Thank you all for dialing in to today’s call. We are excited that we have several hundred
folks on the call, in fact, that are interested in the Quality Payment Program and potentially
interested in becoming one of our qualified registries or qualified clinical data registries. So, we have a decent agenda for you guys today
to give you a bit of an overview, let you know kind of the process that we go through
and the requirements. At the end, when we do take the question and
answer session, if you could try to restrict your questions to registry/QCDR as it relates
to the QPP, that would be helpful. If you have other questions, again, we can
forward them to our QPP — Quality Payment Program — questions center, and they will
respond to you. Also wanted to let folks know in the next
day either by the close of business tomorrow or on Friday we will be posting our self-nomination
documents, which will provide additional information about requirements, et cetera. So, please do be on the lookout for that. We will be sending out a listserv and/or an
e-mail to folks that are participating on today’s call to give you the link once we
have it posted. So, again, thank you. I’ll say buckle up, and we’re glad you could
join us. We can start the presentation, I guess. Hector? Okay. Thank you, Dr. Green. So, what we’ll be going over today will be
the Qualified Registry overview, the Qualified Clinical Data Registry overview, provide some
information in terms of the QCDR measure harmonization process, the data validation plan requirements,
information around the business associate agreement, resources and who to contact for
assistance, and then we’ll also do a walkthrough of the self-nomination form for the 2018 program
year. And then we’ll wrap up with some questions
and answers session at the end. Next slide, please. So, what is a qualified registry? A qualified registry is an entity that collects
clinical data from an individual MIPS-eligible clinician, group, or virtual group, and submits
it to CMS on their behalf. Clinicians work directly with their chosen
registry to submit data on the selected measures or specialty set measures. Virtual groups are combination of two or more
TINs composed of a solo eligible clinician or a group of 10 or fewer eligible clinicians
that elects to form a virtual group with at least one other solo practitioner group. All MIPS-eligible clinicians within a TIN
must participate in the virtual group. We’d also like to note that the virtual group’s
reporting option reflects what is proposed in the calendar year 2018 Quality Payment
Program proposed rule, and the reporting options are subject to change based on what is finalized
in the calendar year 2018 Quality Payment Program final rule. Next slide. So, what are some of the requirements for
a qualified registry? The first one is, you must have at least 25
participants by January 1, 2018. These participants do not need to use the
qualified registry to report MIPS data to CMS, but they must submit data to the qualified
registry for quality improvement. You must also provide a statement during the
data submission period verifying that all the data, such as quality measures, improvement
activities, and advancing care information measures and objectives, if applicable, and
results are accurate and complete. You must also submit data via a CMS-specified
secure method for data submission, such as a defined Quality Payment Program data format,
such as JSON or XML, and additional information regarding data submission methodologies can
be found in the developer tools section of the resources section of the Quality Payment
Program website. And you see the link on the screen. You must also provide information on your
process for data validation for both individual MIPS-eligible clinicians, groups, and virtual
groups within a data validation plan. And results of the executed data validation
plan must be provided by May 31st of the year following the performance period. Next slide. A qualified registry must also perform some
functions related to data submissions. The first is that it should indicate the certified
EHR technology data source, end-to-end electronic reporting, if applicable, performance period
start and end dates, whether you are reporting on advancing care information measures and
objectives, and whether you are reporting on improvement activities. A qualified registry must also submit data
and results for all the MIPS performance categories, and this includes all-payer data, not just
Medicare Part B patients, results for at least six quality measures with at least one outcome
measure — if an outcome measure is not available, use at least one other high-priority measure
— Quality Measure ID numbers for quality measures, measure-level reporting rates by
TIN/NPI and/or TIN, measure-level performance rates by TIN/NPI and/or TIN, risk adjusted
results for any risk adjusted measures, sampling methodology of data validation, performance
categories feedback at least four times a year for all individual MIPS-eligible clinicians. Next slide. Three — report on the number of eligible
instances or report the denominator, times a quality service is performed, which would
be the performance numerator, times the applicable submission criteria were not met, and performance
exclusions, meaning denominator exceptions or exclusions. Qualified registries must also verify and
maintain eligible clinician information, and that is signed verification of clinician names,
contact information, costs charged to clinicians, services provided, measures and specialty-specific
measure sets, if appliable, business agreements with clinicians or groups who provide patient-specific
data. This is to ensure the business associate agreement
complies with HIPAA privacy and Security Rules — and include disclosure of quality measure
results and data on Medicare and non-Medicare beneficiaries — again, all-payer information. Also have signed NPI-holder authorization
to submit results and data to CMS for MIPS, and release all e-mail address for feedback
report distribution. Attestations that all data and results are
accurate and complete must also be done. Five — comply with any CMS request to review
your submitted data, requirements to participate in the mandatory kick-off meeting and monthly
support calls, and also CMS-approved secure method for data submission. Again, either an XML or a JSON file are examples
of those. Next slide. If any data inaccuracies affect more than
three percent of your total MIPS-eligible clinicians, you will be placed on probation
due to your low data-quality rating, and the qualified registry posting will be updated
for the performance period to indicate you are on
probation. Data inaccuracies affecting more than five
percent of your total MIPS-eligible clinicians may lead to being precluded from participating
in the following year. Next slide. Qualified registries, regardless of prior
participation as a registry, must self-nominate on an annual basis to participate in future
program years of MIPS. Having previously qualified as a qualified
registry does not automatically qualify the entity to participate in subsequent MIPS performance
periods. For the 2018 performance period, CMS has established
the self-nomination period from September 1st through November 1, 2017, at 5:00 p.m.
Eastern. Please review the calendar year 2018 Quality
Payment Program proposed and final rules for more information regarding requirements to
be a qualified registry in the 2018 MIPS performing period. You may also visit the resources library of
the Quality Payment Program website for additional information when available about registry
participation for the 2018 MIPS performance period. Next slide. Next slide, please. So, what is a Qualified Clinical Data Registry? A QCDR is a CMS-approved entity that collects
clinical data on behalf of clinicians for data submission. Examples include, but are not limited to,
regional collaboratives and specialty societies. QCDR reporting is different from qualified
registry reporting because QCDRs are not limited to measures within the Quality Payment Program. A QCDR may submit a maximum of 30 QCDR measures,
formerly known as non-MIPS measures, for review and approval by CMS for reporting. QCDRs cannot be owned or managed by an individual
or locally owned speciality group. Next slide. The requirements for a QCDR are similar to
the registry. You must have at least 25 participants by
January 2018, and, again, these participants do not need to use the QCDR to report MIPS
data to CMS, but must submit data to the QCDR for quality improvement. You must also provide a statement during the
data submission period verifying that all the data and results are accurate and complete. For data submission, you must also submit
data via a CMS-specified secure method of data, such as a Quality Reporting Document
Architecture, or QRDA III, or Quality Payment Program data format, such as JSON or XML. Additional information, again, can be found
on the developer tools section of the resource library on the Quality Payment website. And you must also provide information on your
process for data validation for both individual MIPS-eligible clinicians, groups, and virtual
groups within a data validation plan. Results of the executed data validation plan
must be provided by May 31st of the year following the performance period. Next slide, please. QCDRs also have functions related to submitting
data, and they also are similar to the registry, but they differ slightly. So, first, they must indicate Certified Electronic
Health Record Technology data source, end-to-end electronic reporting if applicable, performance
period start and end dates, whether you are reporting on Advancing Care information measures
and objectives, and whether you’re reporting on Improvement Activities. Second, submit data and results for all MIPS
performance categories, again, including all payer data, not just Medicare Part B patients. Submit results for at least six quality measures,
including one outcome measure. And if outcome measure is not available, use
at least one other high-priority measure. And you must also give the entire distribution
of measure results by decile, if available. Quality measure ID numbers for quality measures. Provide measure-level reporting rates for
TIN/NPI and/or TIN. Provide measure-level performance rates by
TIN/NPI and/or TIN. Provide performance category feedback at least
four times a year for all MIPS-eligible clinicians. Provide the sampling methodology for data
validation, risk-adjusted results for any risk-adjusted measures, and any additional
details for QCDR measures, such as data elements and measure specifications, risk-adjusted
results for QCDR quality data, comparison of quality of care by measure, by clinician,
or group, data from before the start of the performance period, if available, also all
Quality Payment Program and QCDR measures to CMS on a designated public website. Provide CMS with the measure specifications,
posts, and links via a JIRA comment in your approved self-nomination form. And this should include the specifications
for your QCDR measures. Next slide. You must also report on the number of eligible
instances, such as the denominator, times a quality service is performed, the performance
numerator, times the applicable submission criteria were not met, performance exclusions,
and approved QCDR measures. Again, just as a reminder, QCDRs may submit
up to 30 QCDR measures for CMS review and approval during the self-nomination period
if desired. You must verify and maintain eligible clinician
information, such as signed verification of clinician names, contact information, services
provided, costs charged to clinicians, measures, and specialty-specific measure sets, if applicable,
business agreements with clinicians or groups who provide patient-specific data, and you
must ensure that the business associate agreement complies with HIPAA Privacy and Security Rules. You also want to include disclosure of quality
measure results of data on Medicare and non-Medicare beneficiaries. Signed NPI-holder authorization to submit
results and data to CMS for MIPS and release e-mail address for feedback report distribution,
also attestation that all data and results are accurate and complete. You must also comply with any CMS request
to review your submitted data. It is also a requirement to participate in
mandatory QCDR kick-off meeting and monthly support calls. And a CMS-approved secure method for data
submission must be used, such as an XML file. Next slide. For QCDR submission, similar to the qualified
registry, if any data inaccuracies affect more than three percent of your total MIPS-eligible
clinicians, you will be placed on probation due to your low-quality data rating. The QCDR qualified posting will be updated
for the performance period to indicate that you are on probation. And data inaccuracies affecting more than
five percent of your total MIPS-eligible clinicians may lead to being precluded from participating
in the following year. Next slide. For self-nomination, similar to the qualified
registries, QCDRs, regardless of prior participation as a QCDR, must self-nomination to participate
in future program years. Having qualified as a QCDR, again, does not
automatically qualify the entity to participate in subsequent MIPS performance periods. And for the 2018 performance period, the self-nomination
period starts September 1st, which is this Friday, and goes through November 1, 2017,
at 5:00 p.m. Eastern. Please review the calendar year 2018 Quality
Payment Program proposed and final rules for more information regarding requirements to
be a QCDR in the 2018 MIPS performance period. As a reminder, as well, visit the resources
library for the Quality Payment Program website for additional information when available
about QCDR participation for the 2018 MIPS performance period. Next slide. In term of harmonization for QCDR measures,
proposed QCDR measures that are similar will be requested to be harmonized. The reason for this is that measure harmonization
between QCDRs provides eligible clinicians a bigger cohort for performance scoring and
benchmarking. Collaboration between QCDRs with similar measures
is encouraged. And QCDRs must decide who or which QCDR would
retain the measure as the measure owner and perform the required measure maintenance as
needed. Please note that harmonized measures must
be updated to align with the measure owner’s measure specifications for each performance
period. In addition, permission to use another QCDR’s
measure should be obtained by the time a QCDR self-nominates for each performance period. This information should be submitted and uploaded
through JIRA at the time of your self-nomination so that the PIMMS team, as well as CMS, can
have that information available during the QCDR measure review. Next slide. For data validation plan requirements, vendors
must provide information on their process for data validation for individual MIPS-eligible
clinicians, groups, and virtual groups within a data validation plan. Results of the executed data validation plan
must be provided by May 31 of the year following the performance period. The following must be provided to fulfill
the requirements of the Data Validation Plan — vendor name, benchmarking capability — for
QCDRs only — process of verifying Quality Payment Program eligibility of MIPS-eligible
clinicians, groups, and virtual groups, process of verifying accuracy of TIN/NPI, process
of calculating reporting and performance rates, process of verifying 2018 QPP or QCDR measures
utilized for submissions, process used for completion of randomized audit, and process
used for completion of detailed audit. Please note that the randomized audit and
detailed audit should not be the same. Next slide, please. In terms of business associate agreement,
you may enter into and maintain with your participating MIPS eligible clinicians an
appropriate Business Associate agreement that provides for the qualified registries or QCDRs
receipt of patient-specific data from an individual MIPS-eligible clinician, group, or virtual
group, as well as the qualified registries or QCDR’s disclosure of quality measure results
and numerator and denominator data and/or patient-specific data on Medicare and non-Medicare
beneficiaries on behalf of MIPS-eligible clinicians, groups, or virtual groups. Next slide. On this screen, you’ll see some resources
that are available. As mentioned throughout the presentation,
you may always refer to the Quality Payment Program website, which is qpp.cms.gov. You may also refer to the Federal Register
or the rule for the program. The Quality Payment Program listserv — we
encourage you to sign up for the listserv if you’re currently not signed up. And this will ensure that you do receive communication
regarding program updates. And also the qualified registry and QCDR support
calls — these are for approved vendors only. And the support calls will be held, again,
approximately once per month for approved vendors. The support calls address reporting requirements,
steps for successful submission, and they also include a question and answer session. Attendance to all support calls is mandatory
and is a requirement of participation. Next slide. For assistance, you can contact the Quality
Payment Program and Merit-based Incentive Payment System Support team at the Quality
Payment Program Service Center. On the screen, you’ll see their phone number
and e-mail address listed. Next slide. And next slide, please. And we’ll now proceed with the demonstration
of the 2018 JIRA self-nomination form. Okay, can everyone see my screen? If I hear silence, that means yes. All right. So, if you’re new to the program and you have
not already done so, we suggest getting a JIRA account. And you would come to the ONC JIRA main page,
and you would click here to sign up for an account. And you would complete this information here,
and following that, you’d be able to sign up for an account. It’s really fast and easy to do. So, once you do that, you can come into the
main log-in page and log in to JIRA. Once you do that, you’ll want to go to the
Projects tab on the page and select the 2018 QPP self-nomination form Project, and it’ll
take you to this page. And what you’ll want to do next is select
Create to start your self-nomination form. Just as a reminder also, self-nomination forms
should be submitted without waiting for the calendar year 2018 Quality Payment Program
final rule to be published, as you will be able to provide updates once they are submitted. One thing that we’ve also implemented this
year is, if you submit your 2018 self-nomination form to CMS, prior to the close of the self-nomination
period — so, prior to November 1st at 5:00 p.m. Eastern — and your application is ready
for review, we ask that you please notify the PIMMS team by e-mailing us at [email protected]
if you’re a QCDR or registry [email protected] if for registries. Please make sure to include your 2018 self-nomination
form JIRA ticket when you do, though, and that information is provided once you submit
the ticket, as well. Also, when you come to this page, you’ll want
to make sure that you select the correct issue type from the drop-down. So, again, if you’re a registry, select the
registry option, and if you’re a QCDR, make sure that you select the QCDR. We’ve had some instances where last year we
had some organizations submit as a registry when they were intending to submit as a QCDR
and vice versa. You’ll also see the different tabs on the
self-nomination form. So, the Field tab provides background information
about the self-nomination process, deadlines, and requirements. The 2018 Registry or QCDR Self-Nomination
tab allows vendors to provid required information regarding their demographics and contact information,
data collection methods, indicate reporting options, performance categories, and services
reported. And I’ll go through a QCDR self-nomination
form so you can see it after I give an overview of the different tabs. The Individual Measures tab allows vendors
to select the individual measures supported by their organization for the 2018 performance
period. And also just to note again that the list
of quality measures below reflects what is proposed in the calendar year 2018 Quality
Payment Program proposed rule. Measure availability is subject to change
based on what is finalized in the calendar year 2018 Quality Payment Program final rule. The QPP eCQMs tab also allows vendors to select
the eCQMs that will be supported by their organization for the 2018 performance period. The Data Validation tab allows vendors to
specify the methodology that will be used for validating the data submitted for the
2018 performance period. And you must also use the Uploads tab. The Uploads tab allows vendors to upload their
benchmarking methodology, QCDR measures, and/or data validation plan. If vendors decide to upload their QCDR measures,
we’re asking that you please utilize the QCDR measure submission template, which will be
posted soon and will be provided, as well. The only difference between the registry and
QCDRs is that the QCDRs will also have a QCDR Sub-tasks tab or option, and that QCDRs may
use to submit their own measures for CMS consideration. Please note that all measures, whether they
are new or previously approved measures, should be submitted as sub-tasks. And as just previously mentioned, we are providing
a QCDR measure submission template that you can use as an alterative to creating sub-tasks. Also, a Resources tab will be added to the
form when you go to self-nomination, and the Resources tab will contain links to the 2018
self-nomination user guide, fact sheets, and a QCDR measure submission template. The QCDR measure template, again, is an alternative
to creating some tasks and can be used to submit all of your measures for CMS review. The 2018 self-nomination user guide, fact
sheets, and QCDR measure submission template are anticipated to be posted by September
1st. An e-mail will also be sent to those participants
registered for today’s demonstration, and that e-mail will include a link to the resources
that I just mentioned. So, in terms of the QCDR self-nomination form,
all fields marked with a plus sign contain information that will be included in the qualified
posting, and the fields noted with an asterisk denote information that’s required. So, I’ll go through one quickly with you on
the phone. Make sure that you have your organization
name. If the QCDR name is different than the organization
name, please note that on the form. If not, you may enter “n/a.” You may enter your street address, suite number,
city, and state. And again, this information will be used to
generate your qualified posting for your organization. Website, your telephone number. This is new, as well, for this year. We’re asking for the telephone number. Sometimes we find that it may be easier just
to pick up the phone and speak with someone directly instead of going back and forth through
e-mail or through the JIRA comments function. So, this year, again, we’ve added the telephone
number field to try to expedite that process. You enter your application name. Please indicate how you would like your self-nomination
form to be saved — for example, “ABCDQCDR.” We also ask that you include your vendor organization
staff — so, other folks that you would like to be included in any communication that’s
done through JIRA. They must also have a JIRA account to be able
to either access the system or receive those notifications. And we’re also asking if you’re a new or existing
QCDR under MIPS, what years you participated under MIPS or PQRS, if you have an alias and
if you have any previous aliases for your entity either under MIPS or PQRS, a description
of your QCDR, whether you plan to risk-adjust, and if you will do your own public reporting
or whether you’ll be reporting through the Physician Compare site. We also ask for cost. In terms of cost, we also ask to please clarify
if the cost is monthly, annually, per submission, per provider. That was one of the fields last year where
we needed to go back to a number of vendors for clarification. So, the more information you provide on the
self-nomination form, the easier it’ll be for us to review in the staff so that we can
get through the self-nomination form review for your organization. Services included with the cost, the data
submission mechanism. If you select Other, we also ask that you
please specify here in that field what that other mechanism will be. Also, if you’re reporting for Improvement
Activities, Advancing Care Information, or if you’re only reporting for Quality. If you’re reporting Quality and any of the
other two, such as Improvement Activities or Advancing Care, please select those, but
if you’re only reporting for Quality, please select the last box. And also reporting options supported — whether
it’s individual MIPS-eligible clinicians, groups, or virtual groups. And as mentioned earlier in the presentation,
the reporting options supported may change. Please review the calendar year 2018 Quality
Payment Program final rule for that information. We also ask for three organization contacts,
and we encourage that you list three different individuals as organization contacts. This will ensure that your entity does not
miss important correspondence due to staff changes, staff limited access to e-mail — if
staff is out on vacation or out of the office. This will ensure JIRA notices are received,
so please have these contacts add ONC JIRA to their safe or approved senders list. For the next half, for the individual measures… Sorry about that. I’m just filling it in so I can show you how
to submit a sub-task at the end. In terms of individual measures, again, you
can select here which Quality Payment Program and quality measures you will be supporting
for 2018. And again, as a reminder, that might change
based on the 2018 Quality Payment Program final rule. So, if you’re going to be supporting all of
them, you can select all or you can select individual measures from the drop-down here. The same applies in terms of the QPP eCQMs,
whether you plan on supporting any of those measures. In terms of the data validation plan, as mentioned
earlier, you can upload that on the Uploads tab and enter See Attachment if you like,
if you have a plan already. Please note that if you previously participated
in PQRS that you should update your data validation plan to reflect the MIPS Quality Payment Program
in your data validation plan. If you plan to benchmark, how will your organization
verify? In this field, we ask that you describe how
your organization will verify the eligibility of eligible clinicians or groups — so, whether
you would use a Medicare provider and bill Medicare Part B services. We also ask how your organization will verify
that accuracy of TINs and NPIs. We also provide further guidance here. The method that your organization will use
to verify the accuracy, such as the national provider identifiers — So, if you’re going
use NPPES, CMS claims or tax documentation to do so, we ask that you specify that here
in your data validation plan. What method your organization will use to
calculate the reporting and performance rates, and how will your organization verify the
2018 QPP and QCDR measures. And again, we’ll ask how you will complete
the randomized audit, as well as the detailed audit, and these two should not be the same. We’ve also included some minimum requirements. So, for a randomized audit, the minimum must
meet the following sampling to meet participation requirements — so, sample three percent of
the 10 NPIs submitted to CMS by the QCDR, with a minimum of 10 TIN/NPIs or a maximum
sample of 50 TIN/NPIs, at least 25 percent of the TIN/NPIs patients, with a minimum sample
of five patients or a maximum of 50 patients should be reviewed. You can also find this information in the
2018 or 2017 Quality Payment Program rules. And again, if you would like to submit or
upload your data validation plan, your benchmarking capabilities, any supplemental QCDR measure
documentation, you can do so on this tab here under Uploads. So, once you’ve done that, you can select
Create. And it’ll create the ticket for you. And note if you’re a QCDR and you would like
to submit the sub-task on JIRA you may do so by coming to the More field and selecting
Create Sub-task. Now, if some of you are on the phone and you’re
currently participating in the program, you’ll notice that this Sub-task area has changed. We’ve added more fields to this part of the
form to try to reduce the number of times that we have to reach out to the vendors to
get information. So, we’re trying to collect a lot more of
that information up front to try to make the process, again, more efficient for this go-around. So, we ask if it’s a new proposed measure,
and then we ask what measure type it is for a QCDR. So, is it a new measure? Is it an existing measure with no changes? Or is it an existing approved measure with
changes? Does this measure, again, belong to another
QCDR, and, if so, which one? This again
will help in terms of harmonization or letting us know that you’re submitting a measure that’s
owned by another entity. And we also ask that you check one whether
you have been granted permission to use this measure or if it’s not applicable because
this is your measure. Again, if you do use another QCDR’s measure,
we do ask that you receive written permission when you self-nominate and that you include
that with your self-nomination. If you’re an existing approved QCDR, we ask
for your CMS-assigned measure I.D. number that was provided to you as part of the measure
specifications. And if it’s a brand-new measure, you can select
N/A for this field. The application type for the field, the description
of the measure, and here you’ll start seeing other or new fields that we’ve added for this
year to reduce the number of communications that are sent out. So, is it a high-priority or an outcome measure? If it is a high priority, we ask you to specify
which one it is, which domain it falls under. We also ask for the NQS domain and for you
to provide rationale for selecting that NQS domain. We ask you for the measure specifications,
which is similar to last year. The biggest change is that we separated out
the exclusions and the exceptions. And we’ve also included a Numerator Exclusions
field this year for you to be able to provide that information. Another new field that we’ve added is if the
measure is an inverse measure. The measure type you can select from the top
down. How the measure is scored — if it’s a proportion
or a continuous variable and if it’s a ratio measure or not. And we also ask for the range of those scores
if it’s a continuous variable or ratio measure if that’s chosen. Also, we ask if the measure is risk-adjusted. And if the measure is risk-adjusted, we ask
how it’s going to be scored. We also ask that you submit your risk-adjustment
methodology, as well, with your self-nomination for 2018. The NQS I.D. number for that measure — if
one does not apply, you can enter zeroes in this field. And the source used for the measure. Is it claimed? Is it the EHR facility discharge, things like
that? The number of performance rates to be submitted
in the XML. You can enter the number or N/A. If only one
is calculated, just indicate that by the number one. We also ask that you provide the name for
each performance rate if there are multiple performance rates for that measure. So, if it’s a multi-strata rate or multi-performance-rate
measure, we ask that you specify that in this field. And we also ask that you indicate an overall
performance rate if more than one performance rate is submitted. We also ask that provide a concise summary
of evidence of a performance cap in addition to any study citations. The citations are great, but if you could
provide a one-paragraph or two-paragraph summary of the citation or citations or the study
there submitted, that would also help us during the measure review part of the process if
we need additional information or, again, just to help us with the review process. And then we have some fields here at the bottom
in terms of indicating which specialty or specialties this measure applies to, if there’s
any variance in the measure rate. If there is, we ask that you indicate the
variances within your registry or another source. If it’s another source, please cite the source. We ask that you please provide any test data
or reliability validity data, and also what is the measure funding source. And once you’re done, again, you can hit Create,
and it’ll create that as a sub-task to your self-nomination form. Once you finish the process, if you do the
self-nomination registry form, once you hit Create, it is automatically sent to CMS. But for the QCDR, since you do have the option
of adding QCDR sub-tasks, you do need to click here to submit to CMS for review. Again, if you submitted your 2018 self-nomination
form to CMS prior to the close of the self-nomination period and your application is ready for review,
we ask that you notify the PIMMS/MIPS team by e-mailing us either at
the [email protected] or [email protected] so that we can begin with the self-nomination
review process and can start processing your application as soon as possible. And you’ll see those sub-tasks listed here
for your organization. We can go to the Q&A session now. Okay, great. Thank you, Hector. And just as a reminder to all the attendees,
only questions pertaining to QCDRs, registries, and the self-nomination process will be answered
during this Q&A session. Okay, so, the first question we have is, “On
slide six, it says you must provide a statement during the data submission period verifying
that all the data is accurate. If participants are uploading the data to
our registry QCDR, is the participant also agreeing to this attestation statement?” So, I assume we’re talking about the attestation
statement that the data is true and accurate and complete to the best of the entity’s knowledge. So, different registries and QCDRs are going
to have different agreements with their eligible clinicians. Some as a requirement for participation — I
think it’s STS perhaps, Society of Thoracic Surgeons — I believe their doctors are obligated
as part of their condition of participation with the registry/QCDR, to submit all of their
cardiac surgeries that are applicable. So, again, it really depends on the agreement
the entity has with their clinician. Great. Next question — “If you are a new QCDR, do
you still need 25 participants?” Yes. You don’t have to report on all 25 people
to us, but you do need to have 25 people that are submitting data to you. Great. Next question — “Where can the application
for self-nomination to become a qualified registry be found?” So, the self-nomination application is available
through the ONC JIRA system, and we will be providing additional resources within the
next day or two, a self-nomination user guide, and some fact sheets that will assist you
with logging in to the website and creating the account and starting your application. Next question — “Is there a more summarized,
concise source for the 2018 QCDR requirements other than the proposed rule?” Yes, we actually have a 2018 QCDR fact sheet
that will be available within the next day or two. We will distribute that through list messaging,
and they will be posted on the CMS website, so please stay tuned for that. Next question — “Does 25 participants mean
25 TINs or 25 clinicians? Clinicians. Okay. Next question — “If we want to change the
name of our QCDR, do we do so on the self-nomination form, or is there another way we need to do
that?” If you’re an existing QCDR and you would like
to change your name for the 2018 performance period, you can do that in your self-nomination
application. Just list your new name in the title of application,
but then in the previous alias, if you can list your 2017 name for our reference. Okay. Next question — “If you a new QCDR and are
unable to sign a contract with 25 participants by January 1, 2018, are you ineligible for
2018?” We’re really looking for people to have 25
participants on board at the time of self-nomination. Again, you don’t have to report on 25 clinicians. Maybe only five of them will ask you to report
for them. But what we’re looking for is we want entities
with proven track records that have been collecting and analyzing and providing feedback reports
to eligible clinicians so that when your clients are playing for all the marbles, so to speak,
it’s not a learning process for you guys with high risk of not being successful. So, that’s part of the reason of the requirement
for 25 people before you self-nominate. Next question — “Will CMS publish a template
or guidelines for the 2018 data validation plan?” So, in the 2018 QCDR/registry fact sheets
that are coming out, we do go into more detail in terms of what we’re looking for, for the
data validation plan, and we pull these requirements directly from the rule. So stay tuned for that, as well. Next question — “Can QCDR submit specialty
measure sets?” Specialty measure sets that have been identified
in MIPS? If the question is that, yes, but we do ask
that QCDRs — and feel free to correct me if I misspeak, Sophia — we do ask them to
report on six measures. I mean, everybody has to report on six measures
in theory, but some of the specialty sets have fewer than six measures — again, not
a lot, but a few. So, that’s the one caveat. Sophia, if you want to elaborate. No, that’s accurate, Dan. I think you covered it well. Great. Next question — “Can a qualified registry
support measures that were not listed at the time of self-nomination for a given program
year? And is this true for 2017, as well?” Sophia, you want to take that? Yeah, sure. So, we encourage our vendors, our approved
vendors, to, when they self-nominate, include all the measures as much to their ability
in their self-nomination application. We have allowed vendors to add additional
measures up until a certain point. But that wouldn’t be throughout the performance
period. It’s for perhaps a few weeks to a month that
we will let them add that information. And we have an internal process that our existing
vendors are aware of, of how they can add existing quality measures to their self-nomination
if they choose to do so. Okay. Next question — “Are the lists of 2018 QPP
measures released? And do we need them for self-nomination? So, currently the list of 2018 quality measures
is available through the proposed rule and, once finalized, will be in the final rule. We are working to get those posted I believe
— Dan, correct me if I’m wrong — by the final rule on the QPP website. And so intermittently, we do have the measure
numbers included in the self-nomination form. So, as you scroll through, you can kind of
do a comparison to the number that’s there versus what’s in the
rule, and the rule will give you the exact measure specification that’s available. Okay. Next question — “What is the non-technical
criteria used to determine if an organization is approved as a QCDR?” So, our largest aspect is looking to see that
they have completed the data validation plan to meet the requirements of the program, their
ability to audit, their ability to verify TIN and NPI combinations. So, we’re really looking to see that they
can do that. Other than that, if you’re a QCDR and you’re
trying to self-nominate — non-MIPS or QCDR measures we’re referring to — we look to
see that the organization is either a medical society or a specialty society or perhaps
the I.T. vendor that’s collaborating with the specialty society that has the clinical
background to support the measures in which they are choosing to self-nominate. So, the requirements are largely around those
areas that we look to see, but, as Dr. Green had mentioned before, the 25 participant requirement
is one thing we also really do look at, so please stay tuned for additional information
on that with regards to the fact sheet. That will be available soon. Thanks. Next question — “Can you please clarify the
difference between a randomized audit and a detailed audit?” I’m not 100 percent sure I understand the
question. If you’re talking about a randomized audit
that we may randomly select, QCDRs are eligible clinicians to audit. That would just be kind of a luck of the draw
for the clinician or QCDR. If we’re talking about audits that the QCDR
or registry should do for their eligible clinicians, we do expect that there will be some sort
of data validation that is done to ensure for a small percentage of the clinicians for
whom the registry or QCDR submits. We would expect that they would go back and
look, again, for some small percentage of their clients to make sure that the information
was, in fact, correct. So, it’s a random kind of luck of the draw
of their clinicians or if there’s a clinician that they have particular concerns about because
of some data peculiarity in the information that was provided to the registry. Okay. Next question — “Can we add additional non-MIPS
measures to our QCDR after the close of the self-nomination deadline?” So, we do not accept additional non-MIPS measures
after the deadline. We ask that you submit those by November 1st
for our review. We will, on a case-by-case basis, allow you
to add quality measures that are in the program, MIPS quality measures. But we do not accept non-MIPS measures after
the deadline. Next question — “What happens if all of our
25 participants back out and we are unable to submit data at the end of the year?” I’m sorry. Can you repeat that last question? Yes — “What happens if all of our 25 participants
back out and we are unable to submit any data at the end of the year?” I believe —
The clinicians are not obligated to report. Nor are the QCDRs. They just have to have 25 to start. Okay. “As an integrated health system, are we eligible
to self-nominate and become a QCDR?” I guess that would depend on if they could
meet the technical requirements and the clinician requirements of becoming a QCDR. So, if you can meet the definition, then you
can apply to be considered as a QCDR for 2018. Okay. Next question — “Does data have to be collected
directly from clinicians, or can a third party be used?” I’m assuming that’s asking if data has to
be submitted from the clinician directly to CMS, but, no, you can use the third-party
intermediary to submit data on behalf of clinicians to CMS. Okay. Next question — “Do approved and existing
QCDR measures mean it was approved for use in 2017? Is the sub-task where we would put our non-MIPS
measures?” So, I guess that was a compound question. Sure. But let me know if you need me to repeat it. No, I think I got it. So, the sub-task is one of the places where
you can add your — if you’re an existing QCDR and you have an approved 2017 non-MIPS
— or we are referring to it now as a QCDR measure — in the program and you would like
to re-self-nominate that for 2018, you could either fill out the sub-task — and you can
identify that it is an approved measure and whether that be with changes or still the
same from last year — or you can — and we didn’t have a chance to show you this, but
we will distribute it with the other 2018 resources. There is a QCDR measure template, and it’s
in the format of an Excel spreadsheet. And you can also include the information in
that spreadsheet in lieu of a sub-task that we will review as a part of QCDR self-nomination
review application process. I’m sorry. Did I answer the second part of the question? I believe so, the sub-task part, yes. Okay, great. Okay. “Do clients of the QCDR and certified registries
have the ability to evaluate companies they have worked with? If so, is this information available to the
public?” I guess like a review? I’m not aware that they’re able to review
— Well, CMS doesn’t post anything in terms of client reviews of vendors, but we do post
on a yearly basis the qualified posting, which lists all of our approved vendors and the
services they offer with the costs they offer and performance categories and measures. So, that is available for the public. The next question is, “What are the requirements
for public reporting if we elect not to use Physician Compare?” We would expect you to post all the results
for the people and the information that was provided to you. Great. Next question — “In addition to several MIPS
quality measures, would proposing several more new QCDR measures as part of our self-nomination
hinder our prospects at successfully achieving approval as a QCDR?” Sorry — what part of that was the question? They were asking if proposing several more
new QCDR measures as part of their self-nomination would hinder their ability to successfully
be approved as a QCDR. No, that would not. It’s an option. QCDRs have the option to submit for consideration
QCDR measures. And they are not required to do so. You can also support just quality measures. But that would not hinder their application
or their review. Next question — “If participating in prior
years as a registry, can we change to a QCDR and meet the criteria of the previous year’s
participation?” Not necessarily. So, we’re looking for QCDRs to be affiliated
with regional health collaboratives of specialty societies or at least be large-scale institutions
like a Cleveland Clinic, Johns Hopkins, health plan — so, you’re talking about large, multi-specialty
organizations. We’re not looking for ABC EHR suddenly converting
from a registry to a QCDR. Okay. Next question — “As a first-time applicant,
I’m wondering what the definition of a QCDR measure is. Are those measures different from the measures
already finalized in MIPS?” Yep, a QCDR measure is different from those
that are finalized in the program. We do define that more clearly in the fact
sheet, but it is a measure that addresses performance gap. It is not a standard-of-care-related measure. It’s something that performs a quality action. We have a checklist of criteria that we do
use, and I believe we did include that in the QCDR fact sheet that will be coming out
in the next two days. Next question — “Do 25 participants mean
25 groups or 25 physicians irrespective of how many groups they belong to?” The latter. Okay. Next question — “Can a qualified registry
also be a Certified Electronic Health Record?” Not a qualified clinical registry unless they
are functioning in conjunction with, again, a specialty society or a regional health collaborative
or something more than just the fact that they’re an EHR. Okay. Next question — “You stated that all 25 participants’
data needs to be submitted to CMS, just to the registry. Is there a minimum amount of data that does
need to be submitted to CMS?” So, when you sign up, you have to basically
represent that you have 25 people participating with your entity. In the end, these folks, all 25 — or you
may get more people on board during the year that want you to submit to CMS, or none of
them may want to participate in the program. So, we don’t require that you submit that
data. However, if we were to look into your self-nomination
and/or audit you in that respect, we would expect that we would find there are 25 clinicians
that you’re providing feedback to and collecting information at the time of your self-nomination. So, again, in the end, they may not decide
to participate this year, and that’s fine, but
you have to have the experience of collecting information from at least 25 clinicians, giving
them feedback — so, processing the measures, calculating the results, and giving them feedback
before you can self-nominate to our program. You can imagine — and even with this requirement,
we’ve had folks — registries and QCDRs — that have not been successful at getting data in
on behalf of some of their clinicians, which puts us in a tough bind because there are
penalties. At least, there were with PQRS. So, if there’s no data submitted, that particular
clinician is automatically going to get a four percent payment adjustment, again, under
PQRS. And we don’t want to penalize people for something
beyond their control, so we have to have as best an assurance as we can to make sure that
you all are able to submit the data properly. Next question — “Can you begin the application
process, save it, and then add to it over the course of the self-nomination period?” So, when you create your self-nomination form,
you can actually — between September 1st and November 1st, you can create it and click
“submit to CMS,” and though it will be routed to us, you have the ability to go back and
edit your application. So, if you decide between now and then you
wanted to add a few more measures and it’s still within the time frame of self-nomination
before November 1st, 5:00 p.m., you can hit the edit button. And you have the edit function now. You could go in and make some additions or
removals as you see fit. Next question — “How are the data inaccuracies
calculated?” So, the data inaccuracies would be calculated
by looking at various pieces of information that we receive, both from the QCDR or registry,
as well as what we’re able to collect from claims. There also would be information that we receive
from the registry or QCDR itself during their data validation process or through their data
validation execution report. Examples of things that we look for are incorrectly
calculated measures, incorrect TINs or NPIs, just to name a few. Next question — “For issues and comments
that come up regarding requests for harmonization, how do you want us to communicate with CMS?” So, for those kind of issues, with harmonization,
if you’re an existing QCDR or you’re planning to be one for 2018, please contact the PIMMS
team at [email protected] Okay. Next question — “If you have a QCDR with
10 LLCs and there are 10 clinicians under each LLC, does that meet the 25-participant
requirement?” I believe so, but, Dan, can you verify? Can you repeat the question, please? Yes — “If you have a QCDR with 10 LLCs and
there are 10 clinicians under each LLC, does that meet the 25-participant requirement?” It would. That would be 100 clinicians. Okay. Next question — “Can the measure information
page data be submitted as a Word document and uploaded, or do all the fields have to
be filled out? Is there a specific format for submitted results
of the data audit plan?” So, this is a two-part question, as well. So, the first part of the question was with
regards to the QCDR measures? Yes. Okay. Yes. So, the QCDR measure — if you choose not
to fill out the sub-tasks, you would have to put in “Please see attached” or something
of that nature in the field because it wouldn’t let you submit otherwise. And you can attach your document. We prefer that you use the QCDR measure template,
which is in Excel format. It just ensures that you capture all the information
that we need for our review and minimalizes the number of times we have to request information
from our vendors. So, if you could please use that, we’d prefer
it. The second part of the question — can you
repeat that? Yes — “Is there a specific format for submitted
results of the data audit plan?” I don’t believe so. Dan, is there one that you’re aware of? What about the data validation plan? I’m sorry. I missed it. Is there a specific format in which it should
be submitted? Well, I think we do — and I don’t know if
Anastasia’s on the call, but I do believe we provide — I don’t know if it’s a template,
exactly, or an example. This is Anastasia. So, we don’t provide an example, per se, but
within the JIRA form, there are different fields that we request specific answers to. And then of course the self-nomination fact
sheet just contains some information regarding the requirements of kind of what we’re looking
for in those validation plans. And then of course if you do have specific
questions about any of those components, you’re more than welcome to submit an incident through
your QPP Service Center, and we can certainly walk you through that and provide more information. Okay. Next question — “Why is there a max of 30
QCDR measures? And will this change?” We don’t have any imminent plans to change
the number. The 30 is partly due to resources to be able
to review them, but at the same time, since clinicians only have to report on six measures,
that’s quite a few measures that they can choose from. We don’t say, for example, that ABC vendor,
in collaboration with the dermatology — I’m making this up, of course — the Dermatology
Society of America could be one QCDR. ABC vendor in conjunction with the Orthopedic
Associates of America could be another QCDR. So, you can have multiple QCDRs, as long as
each one meets the requirements. And each one, in theory, could have 30 QCDR
measures. But that’s kind of the rationale behind it. Again, you should know that we do go through
these measures and we do try to hold them to a very similar standard to measures that
we place on our Measures Under Consideration list, which would be
measures that we would potentially evaluate for inclusion in the program as a whole. Okay. Next question — “Can a given QCDR address
the MIPS needs of multiple specialties?” “Can a MIPS QCDR –” Can you repeat it again? Yes — “Can a given QCDR address the MIPS
needs of multiple specialties?” They’re not precluded from doing that. You might have a QCDR that is using all primary-care
type measures. And you may have a gastroenterologist that
feels that those measures represent his or her practice well and decide that they want
to participate. Unless there’s a rule against participation
in the QCDR by the QCDR — in other words, if they limit it to certain types of specialties
— that would be on them. But we don’t say that a G.I. doctor couldn’t
report on an orthopedic QCDR. I can’t imagine that they’d want to, but there’s
no prohibition against it from CMS. Okay. “If we did not mention about ACI and IA reporting
at the time of registration, can we still support it later in the program year?” I don’t believe so. Sophia, can you confirm that, please? Yeah, you’re correct, Dan. We do ask for that information at the time
of self-nomination, and if you, in between our review, decide to add that, we do take
it into consideration. But once the services and the QCDRs and registries
have been approved and finalized, we post your services and your performance categories
on our website, so we do ask that you make those considerations when you make your decisions
about what you plan to offer as services. On top of it, I think that the production
team also may code the system to look for certain types of information. I’m not 100 percent on that, but that does
ring a bell. Okay. Next question — “Is there a minimum number
of MIPS-approved measures that a QCDR must support for 2018? Can a QCDR support only non-MIPS measures
and still be approved? Yes. Go ahead. Sorry. Go ahead, Sophia. So, I was gonna say, a QCDR can support both,
obviously, but if they choose to only support non-MIPS measures, they have to make sure
that they have at least six and one of them is at least a high-priority or an outcome
measure. And so what we do in our review — if a QCDR
only submits six non-MIPS measures and they don’t submit any quality measures and for
some reason that one measure is rejected, leaving them with only five approved measures,
we do go back to the QCDR and we do ask them to add a quality measure to get them up to
that six because six measures is the minimum. Whether it be a QCDR measure or a quality
measure or a mix of both, we ask that you support six in order to participate in the
program. Okay. Next question — “If you select all QPP measures
for the QPP measure selection, is that for registry claims measures only, or would that
include all QPP eCQMs, as well? So, since there is a different tab that distinguishes
eCQMs from the QPP measures, we would take the all-QPP measures to represent those that
are for registry or the claims-based measures. So, if you want to do the eCQMs, you would
have to fill out the eCQM tab, as well. Next question — “Does CMS validate data at
the time of self-nomination, or is it only after the completion of the performance year?” So, we validate the data that’s submitted
during the performance period after the submission period is closed. Okay. Next question — “If we submit an application
to be a QCDR, we enter the measures that we intend to support after the specifications
are released and we find there is a measure or measures we cannot report due to limitations
in our workflow, can we withdraw those measures?” So, if we’re speaking about the MIPS quality
measures that are in the program and you see that, between your approval and the time — there
is a time in between where we have our approved vendors review their qualified posting before
it’s posted. So, if in that instance you see that there’s
a measure you can no longer support, that is your last opportunity to let us know that
you cannot support that measure, and we will remove it from your posting and make note
of it in your application just for our reference, but that’s the last time we can actually remove
a quality measure from your posting. Okay. Next question — “Do QCDRs have to submit
the QRDA style provided by clinicians?” So, they don’t have to. If a clinician is reporting an eCQM in QRDA
III, they stand to get an extra bonus point for electronic submission. So, your clinician is going to be very unhappy
with you if you can’t support that and that’s how they want to report, especially if you
advertise as being able to accept electronic measures. So, that’s kind of the caveat there, if you
will. There’s no requirement from us exactly, but
you would be cheating your clinician out of a bonus point. Okay. Next question — “How is the audit different
from the data validation? What’s the difference between the processes?” So, if we audit you guys or your clinician,
we’re going to request records and charts and whatever. If you do a data validation of your clinician,
you may request the same things, but it would be you doing it versus us doing it. Okay. Next question — “For non-QPP QCDR measures,
is there any issue if no physicians end up selecting them for reporting to CMS?” Are there any issues if people don’t want
to report the QCDR measures? Yes, I believe that’s what the question is
asking. No. Okay. Next question — “How does the sampling methodology
work?” Sampling methodology. Anybody else understanding the question? Dan, I think they’re referring to the sampling
methodology. We asked them for the randomized audit. I believe it was at three percent. That’s up to them then. I think they’re asking what our requirement
is. Hector? Do you or Anastasia want to take that? Yeah. This is Anastasia. I can definitely tackle that. So, as suggested in the self-nomination fact
sheet for all of the eligible clinicians, as well as the various measures and instances
that you report on behalf of, we encourage each vendor to audit a certain sample of that
data you’re submitting to ensure that the data you’re submitting is accurate, complete. It does of course apply to what’s written
in the measure specification and it’s been calculated correctly and whatnot. So, this is just asking you to take a certain
percentage or a portion of your data to just verify that everything is, in fact, correct. And then I believe part of that is also to
submit after, of course, you collect this data and submit it to CMS for the data validation
execution report. CMS would like to see the results of that
sampling methodology to see what you found in your results. You know, was there inaccurate data? Did you find that perhaps something wasn’t
coded correctly in your system? Or perhaps a measure wasn’t calculated correctly. Or maybe everything was perfect and you guys
were rock stars. Whatever you guys happen to see when auditing
that data is kind of what we’d like to see in the execution report. And of course that wouldn’t be due until after
the submission, so it would be well into 2019. Okay. Next question — “Can the qualified registry
get clinical data from the practice’s claims data or from their payers?” Can you say that again? “Can the qualified registry get clinical data
from a practice’s claims data or from their payers?” They can get the data from — I’m not understanding. Sophia, are you understanding the question? Not really. I think we need some clarification from the
questioner. Okay. This is Anastasia. I might be able to tackle this one. In reading the specific question in the box,
it sounds as if they’re just wondering if they can actually use claims-based method
for their data-collection method or collect that data and then calculate accordingly from
claims. Yeah, I mean, they can get a copy of claims
if they want as their data source if the clinician is, in fact, listing — I’m sorry — if the
clinician is appending quality data codes. Okay. Next question — “The result of the executed
data validation plan must be provided by May 31 of the year following the performance period,
but in what form and manner?” So, basically we’re asking that you go out
and you — if it’s a certain percentage of clinicians that you’re going audit or whatever,
that you are going go out and perform that audit and write up, you know, “We audited
X number of clinicians and we looked at Y number of charts and this is what we found. The data was accurate. Two percent of clinicians had inaccurate information.” Whatever it was. I don’t know what else to say about that. Anastasia or Sophia, do you have anything
else to add? Anastasia, is there anything with the format? I know we discussed — I guess what Anastasia
had mentioned earlier with the data validation plan — those specific questions we ask in
the self-nomination form and basically your responses to that and how you executed each
aspect of that data validation form would probably be like, I’m assuming, in a Word
document or something like that, as in a report for us to review. But that’s all I have to add. Yeah, Sophia, that’s absolutely correct. Sometimes we will get it in a Word format. Sometimes we do get it in Excel. The one thing I will say is, just because
different vendors develop their own validation plans and then execute them in a wide variety
of different methods and whatnot, it’s hard for us to develop one sort of template that
will apply to all vendors because each of you may be doing your validation in different
mechanisms. Maybe some of it’s being exported from a system. Other folks may be generating it manually. In addition, the various ways folks collect
data, whether it be claims, Web-based tool, practice management system, EHR, there may
be different ways to validate that data in that mechanism, as well. So, we’ve found that just letting the vendors
identify the best mechanism to send in these reports has been the most ideal just because
there is such a wide variety of different ways to validate the data that folks are sending
in and collecting. Okay. Next question — “Irrespective of if a practice
participates in MIPS via our qualified registry or a QCDR, are they still able to pick your
pace, do the test submission in one chart for 2018?” Sophia, I’m gonna pass that one to you. I think we need to take this question back
to the team. I’m not sure because this is asking of the
2018 performance period, and since the rule hasn’t been finalized —
Good call. Yes, that’s true. We can’t answer that question in this period. Yeah. Okay. Great. Thank you all. I did want to note that it is 2:29 right now,
so I’ll leave it up to the presenters if we would like to take one more question or close
out the call for this afternoon. I just wanted to clarify one question that
I see in the Q&A box because it was related to an answer that I provided earlier with
regards to whether the QCDR could support only QPP measures or not. QCDRs can support QPP measures that are MIPS
quality measures that are already in the program as established by the rule, or they can submit
QCDR measures that are owned and developed by the QCDR. Or they can do a mix of both, but they’re
not required to do one or the other. It’s up to the QCDR and their capabilities. That’s the only clarification that I wanted
to make. So, I think if we’re done, I just want to
thank everybody for your interest in the program and your potential interest in participating. We hope this call was helpful. There will be additional information that’s
posted on the cms.gov website in the next day or so. We would ask you to look out for it, and we
will provide links once we have them available. Thank you, and any additional questions that
were not answered today, feel free to submit them to the QPP portal — and Sophia can run
through that address real quick before we hang up — and we will route them to the appropriate
subject-matter expert. Thanks again for dialing in. Sophia, do you want want to give that address
real quick? Sure. So, it’s the Quality Payment Program Service
Center, and the e-mail address is [email protected] And your question, whether it be related to
quality, ACI or IA or scoring or any of the other policy related areas, will be directed
to the appropriate subject-matter expert for an answer. Thank you all. Have a good day. Bye. Thank you. This concludes today’s conference. You may now disconnect. Speakers, please hold the line.

Leave a Reply

Your email address will not be published. Required fields are marked *